JP2023543132A5 - - Google Patents

Info

Publication number
JP2023543132A5
JP2023543132A5 JP2023513678A JP2023513678A JP2023543132A5 JP 2023543132 A5 JP2023543132 A5 JP 2023543132A5 JP 2023513678 A JP2023513678 A JP 2023513678A JP 2023513678 A JP2023513678 A JP 2023513678A JP 2023543132 A5 JP2023543132 A5 JP 2023543132A5
Authority
JP
Japan
Prior art keywords
cyclodextrin
hydroxypropyl
individual
amount
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023513678A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543132A (ja
JP7895334B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/048075 external-priority patent/WO2022047244A1/en
Publication of JP2023543132A publication Critical patent/JP2023543132A/ja
Publication of JP2023543132A5 publication Critical patent/JP2023543132A5/ja
Application granted granted Critical
Publication of JP7895334B2 publication Critical patent/JP7895334B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023513678A 2020-08-27 2021-08-27 シクロデキストリンによるコレステロール結晶塞栓症の予防方法 Active JP7895334B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063071243P 2020-08-27 2020-08-27
US63/071,243 2020-08-27
PCT/US2021/048075 WO2022047244A1 (en) 2020-08-27 2021-08-27 Methods for the prevention of cholesterol crystal embolization with cyclodextrins

Publications (3)

Publication Number Publication Date
JP2023543132A JP2023543132A (ja) 2023-10-13
JP2023543132A5 true JP2023543132A5 (cg-RX-API-DMAC10.html) 2024-08-27
JP7895334B2 JP7895334B2 (ja) 2026-07-27

Family

ID=80352440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023513678A Active JP7895334B2 (ja) 2020-08-27 2021-08-27 シクロデキストリンによるコレステロール結晶塞栓症の予防方法

Country Status (11)

Country Link
US (1) US20230302042A1 (cg-RX-API-DMAC10.html)
EP (1) EP4203973A4 (cg-RX-API-DMAC10.html)
JP (1) JP7895334B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230096976A (cg-RX-API-DMAC10.html)
CN (1) CN116635007A (cg-RX-API-DMAC10.html)
AU (1) AU2021331485A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023003490A2 (cg-RX-API-DMAC10.html)
CA (1) CA3190764A1 (cg-RX-API-DMAC10.html)
IL (1) IL300881A (cg-RX-API-DMAC10.html)
MX (1) MX2023002420A (cg-RX-API-DMAC10.html)
WO (1) WO2022047244A1 (cg-RX-API-DMAC10.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
WO2013155485A2 (en) * 2012-04-13 2013-10-17 Alessia Fornoni Method of using cyclodextrin

Similar Documents

Publication Publication Date Title
CN1917866B (zh) 曲前列环素或它的衍生物,或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途
CA2684450C (en) Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding
JP2000514091A (ja) 心筋症の処置
Butler et al. Amphotericin B renal toxicity in the dog
JP2024519629A (ja) 血管新生性眼疾患の治療のための長期の高用量vegfアンタゴニストレジメン
JP2002520287A (ja) 黄斑変性における血管新生の予防的治療
JP2023543133A5 (cg-RX-API-DMAC10.html)
JP2020521755A5 (cg-RX-API-DMAC10.html)
JP7835735B2 (ja) シクロデキストリンによるコレステロール結晶塞栓症の治療方法
Wacker et al. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major
JP2024026871A (ja) 慢性便秘症を治療するための医薬組成物
Steigerwalt et al. Nonarteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids
JP2018108993A (ja) 注腸剤
JP2023543131A5 (cg-RX-API-DMAC10.html)
Wizemann et al. Biphasic action of prostacyclin on intraocular pressure
JP2025508660A5 (cg-RX-API-DMAC10.html)
CN107854580A (zh) 一种降脂的中药组合物及其制备方法
WO2017015691A1 (de) Konzentrat enthaltend alprostadil
KR101768809B1 (ko) 덱사메타손 및 글리벤클라마이드를 포함하는 뇌졸중의 예방 또는 치료용 약학적 조성물
HK40073572B (en) Treatment of alcoholic hepatitis
JP2023543132A (ja) シクロデキストリンによるコレステロール結晶塞栓症の予防方法
JPS5920221A (ja) レイノ−症状の改善・治療剤
Sessions Intensive giycemic controi associated with increased mortaiity in high-risi< patients
Jones Sclerotherapy of bleeding esophageal varices
Pascarella et al. Non-arteritic Posterior Ischaemic Optic Neuropathy Treated with Intravenous Prostaglandin El and Oral